Keith Bodger

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Topics

Clinical Practice

Ulcerative Colitis

Venous Thromboembolism

Top Venues

Alimentary pharmacology & therapeutics

PharmacoEconomics

Journal of Crohn's & colitis

This page only lists publications with an associated author ORCID identifier.

Publications

Gerum G Gebeyehu, Frederick Taylor, Liz Dobson, Fraser Cummings, Stuart Bloom, Nicholas A Kennedy, Paul Christiansen, Keith Bodger
Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: Secondary analysis of a nationwide electronic survey. Journal of Crohn's & colitis (2023)
Keith Bodger, Thomas Mair, Peità Schofield, Benjamin Silberberg, Steve Hood, Kate M Fleming
Outcomes of first emergency admissions for alcohol-related liver disease in England over a 10-year period: retrospective observational cohort study using linked electronic databases. BMJ open 13 (11) (2023)
Keith Bodger, Ashwin D Dhanda, null null
Editorial: the burden of alcohol-related liver disease emergency admissions in England may be twice as high as previously thought-authors' reply. Alimentary pharmacology & therapeutics 57 (4) (2023)
Ashwin D Dhanda, Keith Bodger, Steve Hood, Clive Henn, Michael Allison, Chioma Amasiatu, Robyn Burton, Matthew Cramp, Ewan H Forrest, Meetal Khetani, Alastair MacGilchrist, Steven Masson, Richard Parker, Nick Sheron, Ken Simpson, Nikhil Vergis, Martin White, null null
The Liverpool alcohol-related liver disease algorithm identifies twice as many emergency admissions compared to standard methods when applied to Hospital Episode Statistics for England. Alimentary pharmacology & therapeutics (2022)
Keith Bodger
Editorial: rising rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease in the USA. Alimentary pharmacology & therapeutics 56 (7) (2022)
Violeta Razanskaite, Constantinos Kallis, Bridget Young, Paula R Williamson, Keith Bodger
Heterogeneity in outcome assessment for inflammatory bowel disease in routine clinical practice: a mixed-methods study in a sample of English hospitals. BMJ open 11 (12) (2021)
Keith Bodger
Editorial: time trends in colectomy rates for ulcerative colitis in England-mixed methods brings mixed messages? Alimentary pharmacology & therapeutics 53 (5) (2021)
Keith Bodger, null null
Editorial: UK quality of care drive improving ulcerative colitis hospital outcomes. Author's reply. Alimentary pharmacology & therapeutics 50 (5) (2020)
Heather Catt, Keith Bodger, Jamie J Kirkham, Dyfrig A Hughes
Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn's Disease. PharmacoEconomics 37 (12) (2020)
Tristan Townsend, Violeta Razanskaite, Susanna Dodd, Daniel Storey, Stephanie Michail, James Morgan, Michael Davies, Douglas Penman, Christopher Watters, Mira Swaminathan, Joseph Sabine, Adam Chapman, Philip J Smith, Paul K Flanagan, Ian Reilly, Keith Bodger, Sreedhar Subramanian
Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease. Alimentary pharmacology & therapeutics 52 (8) (2020)
Constantinos Kallis, Pete Dixon, Benjamin Silberberg, Lynn Affarah, Mustafa Shawihdi, Ruth Grainger, Nancy Prospero, Mike Pearson, Anthony Marson, Subramanian Ramakrishnan, Paul Richardson, Steve Hood, Keith Bodger
Reducing variation in hospital mortality for alcohol-related liver disease in North West England. Alimentary pharmacology & therapeutics 52 (1) (2020)
Mustafa Shawihdi, Susanna Dodd, Constantinos Kallis, Pete Dixon, Ruth Grainger, Stuart Bloom, Fraser Cummings, Mike Pearson, Keith Bodger
Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005-2013. Alimentary pharmacology & therapeutics 50 (2) (2019)
Heather Catt, Dyfrig A Hughes, Jamie J Kirkham, Keith Bodger
Systematic review: outcomes and adverse events from randomised trials in Crohn's disease. Alimentary pharmacology & therapeutics 49 (8) (2019)